EMCDDA Home
  • EN
Search

Publication search result

To order publications by title, year of publication, type of publication or available languages, please click on the table header in the corresponding column. Search again

Displaying publications f type: Risk assessments
Title Year of publication Type of publication Available languages
Risk Assessment Report of a new psychoactive substance: 1-cyclohexyl-4-(1, 2-diphenylethyl)piperazine (MT-45) 2014 Risk assessments en
Risk assessment of 4-methyl-5-(4-methylphenyl)-4, 5-dihydrooxazol-2-amine (4, 4′-dimethylaminorex, 4, 4′-DMAR 2014 Risk assessments en
Report on the risk assessment of 1-(1, 3-benzodioxol-5-yl)-2-(pyrrolidin-1-yl)pentan-1-one (MDPV) in the framework of the Council Decision on new psychoactive substances 2014 Risk assessments en
Report on the risk assessment of 2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone (methoxetamine) in the framework of the Council Decision on new psychoactive substances 2014 Risk assessments en
Report on the risk assessment of 2-(4-iodo-2, 5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25I-NBOMe) in the framework of the Council Decision on new psychoactive substances 2014 Risk assessments en
Report on the risk assessment of 3, 4-dichloro-N-{[1-(dimethylamino)cyclohexyl]methyl}benzamide (AH-7921) in the framework of the Council Decision on new psychoactive substances 2014 Risk assessments en
Report on the risk assessment of 4-methylamphetamine in the framework of the Council Decision on new psychoactive substances 2014 Risk assessments en
Report on the risk assessment of 5-(2-aminopropyl)indole in the framework of the Council Decision on new psychoactive substances 2014 Risk assessments en
Report on the risk assessment of mephedrone in the framework of the Council Decision on new psychoactive substances 2011 Risk assessments en
Risk assessment of new psychoactive substances — operating guidelines 2010 Risk assessments en
Report on the risk assessment of BZP in the framework of the Council decision on new psychoactive substances 2009 Risk assessments en
Early-warning system on new psychoactive substances — operating guidelines 2007 Risk assessments en
Report on the risk assessment of TMA-2 in the framework of the joint action on new synthetic drugs 2004 Risk assessments en
Report on the risk assessment of 2C-I, 2C-T-2 and 2C-T-7 in the framework of the joint action on new synthetic drugs 2004 Risk assessments en
Report on the risk assessment of PMMA in the framework of the joint action on new synthetic drugs 2003 Risk assessments en
Report on the risk assessment of GHB in the framework of the joint action on new synthetic drugs 2002 Risk assessments en
Report on the risk assessment of ketamine in the framework of the joint action on new synthetic drugs 2002 Risk assessments en
Report on the risk assessment of 4-MTA in the framework of the joint action on new synthetic drugs 1999 Risk assessments es
Guidelines for the risk assessment of new synthetic drugs 1999 Risk assessments en
Report on the risk assessment of MBDB in the framework of the joint action on new synthetic drugs 1999 Risk assessments en

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00

More contact options >>

Page last updated: Wednesday, 17 December 2014